ALLERGAN INC 4
4 · ALLERGAN INC · Filed Oct 5, 2005
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2005-10-03$90.55/sh+27.61$2,500→ 28,166.09 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-10-03$90.55/sh+82.83$7,500→ 28,138.48 total→ Common Stock (0 underlying)
Footnotes (3)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.
- [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.